Lucentis and Coughing - a phase IV clinical study of FDA data

Summary:

Coughing is reported as a side effect among people who take Lucentis (ranibizumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Avastin, and have Age-related macular degeneration.

The phase IV clinical study analyzes which people have Coughing when taking Lucentis. It is created by eHealthMe based on reports of 25,577 people who have side effects when taking Lucentis from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Coughing?

Coughing is found to be associated with 3,176 drugs and 3,775 conditions by eHealthMe. Check the latest studies of Coughing.

On Jul, 21, 2025

25,577 people reported to have side effects when taking Lucentis.
Among them, 299 people (1.17%) have Coughing.

Among these 299 people:

How long have people been on Lucentis when they have Coughing? *

What is the gender of people who have Coughing when taking Lucentis? *

female: 81.37 %
male: 18.63 %

What is the age of people who have Coughing when taking Lucentis? *

What are other drugs people take besides Lucentis? *

What are other side effects people have besides Coughing? *

Headache (pain in head): 100 people, 33.44%
Age-Related Macular Degeneration: 86 people, 28.76%
Dry Throat: 86 people, 28.76%
Photopsia (presence of perceived flashes of light): 85 people, 28.43%
Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 83 people, 27.76%
Throat Tightness: 81 people, 27.09%
Hoarseness Or Changing Voice: 70 people, 23.41%
Dyspnea (difficult or laboured breathing): 32 people, 10.70%
Fatigue (feeling of tiredness): 30 people, 10.03%
Nasopharyngitis (inflammation of the nasopharynx): 26 people, 8.70%

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 23 people, 7.69%
High Blood Pressure: 17 people, 5.69%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 17 people, 5.69%
Diabetes: 10 people, 3.34%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 8 people, 2.68%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 7 people, 2.34%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 7 people, 2.34%
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest): 7 people, 2.34%
High Blood Cholesterol: 6 people, 2.01%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 6 people, 2.01%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and have Coughing?

- Check whether Coughing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lucentis:

Lucentis (25,647 reports)

Coughing treatments and more:

Coughing (361,780 reports)

Common Lucentis side effects:

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Coughing:

Browse all the drugs that are associated with Coughing:

Coughing (3,176 drugs)

Common conditions associated with Coughing:

Asthma: 28,759 reports
Chronic asthma: 28,706 reports
Rheumatoid arthritis: 28,588 reports
Arthritis - rheumatoid: 28,587 reports
Hypertension: 16,159 reports
Hbp: 16,068 reports
Familial primary pulmonary hypertension: 12,453 reports
Ms: 9,445 reports
Granulomatous ileocolitis: 8,547 reports
Psoriasis: 8,534 reports

Browse all the conditions that are associated with Coughing:

Coughing (3,775 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.